Chuang, Huai-Yao <br/><br/>
Toward reducing immunogenicity of enzyme replacement therapy: altering the specificity of human β-glucuronidase to compensate for α-iduronidase deficiency.  [electronic resource] 

 -  Protein engineering, design & selection : PEDS  Nov 2015 
 - 519-29 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1741-0134 
<br/><br/><label>Standard No.: </label>10.1093/protein/gzv041  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acid Sequence<br/>Enzyme Replacement Therapy--adverse effects<br/>Glucuronidase--chemistry<br/>HEK293 Cells<br/>Humans<br/>Iduronidase--deficiency<br/>Models, Molecular<br/>Mucopolysaccharidoses<br/>Protein Engineering